HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL)

Eiser, C., Davies, H., Jenney, M. et al. (2 more authors) (2006) HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL). Pediatric Blood & Cancer, 46 (1). pp. 35-39. ISSN 1545-5009

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2005 Wiley-Liss, Inc.
Keywords: ALL; dexamethasone; HRQOL; prednisone
Dates:
  • Published: January 2006
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Science (Sheffield) > Department of Psychology (Sheffield)
The University of Sheffield > Faculty of Social Sciences (Sheffield) > Management School (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 15 Aug 2016 12:10
Last Modified: 03 Nov 2016 05:06
Published Version: http://dx.doi.org/10.1002/pbc.20432
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: https://doi.org/10.1002/pbc.20432

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)